Federal government moves to reclassify marijuana, easing decades-old restrictions

The Department of Justice is taking steps to loosen federal restrictions on marijuana.

"I'm Shay McAlister, and this is Shay Informed: an independent, ad-free platform dedicated to honest journalism with compassion and clarity.

Are you new here? Sign up for the free weekly newsletter or subscribe to support our mission and access behind-the-scenes content, podcasts, and in-depth stories reserved for paid subscribers.

Acting Attorney General Todd Blanche announced Thursday the Department of Justice is immediately rescheduling FDA-approved marijuana and state-licensed marijuana from Schedule I to Schedule III under the Controlled Substances Act.

That's a significant change- Schedule I drugs are classified as having no accepted medical use and a high potential for abuse, putting marijuana in the same category as heroin. Schedule III includes drugs like ketamine and certain anabolic steroids, which are considered to have moderate to low potential for dependence.

Blanche framed the decision as a healthcare move, not just a drug policy one. His post on social media pointed to expanding patient access to treatment and giving doctors better information to guide care.

The DOJ is also ordering a new, expedited hearing with set deadlines to pursue full rescheduling of marijuana- meaning this may just be the first step in a longer process.

The announcement is notable given the source. Rescheduling efforts under the Biden administration stalled and faced significant political headwinds. Now, under a Republican administration, the push is being framed around healthcare access and research- a reframe that could give it more staying power politically.

The practical implications are wide-ranging. Rescheduling to Schedule III would open the door to more federally sanctioned research on marijuana's safety and effectiveness, something scientists and doctors have long said is needed. It could also ease some of the financial and legal burdens on state-licensed cannabis businesses that currently operate in a legal gray zone.

What does it mean for Kentucky?

Kentucky's medical cannabis program is barely off the ground- first sales began in December 2025. Only a few dispensaries are actually open across the state.

Business perks

But those business could see some financial benefits from this move. Under current federal law, cannabis businesses- even state-legal ones- can't deduct normal business expenses on federal taxes because of a tax code provision tied to Schedule I status. Moving to Schedule III would likely eliminate that burden, potentially making Kentucky dispensaries significantly more profitable and viable.

More access for patients

Cannabis consumption outside of the medical cannabis program remains illegal in Kentucky, and that doesn't change with this federal move. But for the thousands of Kentuckians who are registered medical cannabis patients, rescheduling could matter in meaningful ways. It signals federal legitimacy for what doctors are already recommending, and it could push more physicians to get comfortable certifying patients. There are currently over 500 practitioners recommending cannabis in Kentucky and that number could grow.

More research

Rescheduling would open the door to federally sanctioned clinical research that simply hasn't been possible under Schedule I. That's significant for Kentucky, which has its own qualifying conditions framework that the state is already being asked to expand. The Office of Medical Cannabis sent a recommendation to legislative leadership in February 2026 to expand qualifying medical conditions. Better federal research could accelerate and strengthen that process.

What it doesn't change

Recreational marijuana remains fully illegal in Kentucky, and this federal action doesn't touch that. Employers can continue enforcing drug-free workplace policies, and employees may still face discipline or termination for cannabis use even if they are legal cardholders.

Like what you see? Learn more about Shay Informed here! This is honest journalism with compassion and clarity.